Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Biometals ; 23(4): 601-11, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20596754

ABSTRACT

Siderophores are biosynthetically produced and secreted by many bacteria, yeasts, fungi and plants, to scavenge for ferric iron (Fe(3+)). They are selective iron-chelators that have an extremely high affinity for binding this trivalent metal ion. The ferric ion is poorly soluble but it is the form of iron that is predominantly found in oxygenated environments. Siderophore uptake in bacteria has been extensively studied and over the last decade, detailed structural information for many of the proteins that are involved in their transport has become available. Specifically, numerous crystal structures for outer membrane siderophore transporters, as well as for soluble periplasmic siderophore-binding proteins, have been reported. Moreover, unique siderophore-binding proteins have recently been serendipitously discovered in humans, and the structures of some of their siderophore-complexes have been characterized. The binding pockets for different ferric-siderophores in these proteins have been described in great molecular detail. In addition to highlighting this structural information, in this review paper we will also briefly discuss the relevant chemical properties of iron, and provide a perspective on our current understanding of the human and bacterial iron uptake pathways. Potential clinical uses of siderophores will also be discussed. The emerging overall picture is that iron metabolism plays an extremely important role during bacterial infections. Because levels of free ferric iron in biological systems are always extremely low, there is serious competition for iron and for ferric-siderophores between pathogenic bacteria and the human or animal host.


Subject(s)
Bacteria/metabolism , Iron/metabolism , Siderophores/metabolism , Animals , Humans , Immunity, Innate , Iron/chemistry , Iron Chelating Agents/metabolism , Iron Chelating Agents/therapeutic use , Lipocalins/chemistry , Models, Molecular , Protein Conformation , Siderophores/chemistry , Siderophores/therapeutic use
2.
Biochem J ; 399(2): 225-9, 2006 Oct 15.
Article in English | MEDLINE | ID: mdl-16817779

ABSTRACT

Various bacterial pathogens secrete toxins, which are not only responsible for fatal pathogenesis of disease, but also facilitate evasion of host defences. One of the best-known bacterial toxin groups is the mono-ADP-ribosyltransferase family. In the present study, we demonstrate that human neutrophil alpha-defensins are potent inhibitors of the bacterial enzymes, particularly against DT (diphtheria toxin) and ETA (Pseudomonas exotoxin A). HNP1 (human neutrophil protein 1) inhibited DT- or ETA-mediated ADP-ribosylation of eEF2 (eukaryotic elongation factor 2) and protected HeLa cells against DT- or ETA-induced cell death. Kinetic analysis revealed that inhibition of DT and ETA by HNP1 was competitive with respect to eEF2 and uncompetitive against NAD+ substrates. Our results reveal that toxin neutralization represents a novel biological function of HNPs in host defence.


Subject(s)
Diphtheria Toxin/metabolism , Exotoxins/metabolism , alpha-Defensins/metabolism , Adenosine Diphosphate Ribose/metabolism , Animals , Cell Death , Corynebacterium diphtheriae/physiology , HeLa Cells , Humans , Kinetics , Mice , NAD/metabolism , Peptide Elongation Factor 2/metabolism , Protein Binding , Substrate Specificity , Thermodynamics
SELECTION OF CITATIONS
SEARCH DETAIL